Active Shortage

TOUJEO DOUBLESTAR

SANOFI-AVENTIS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TOUJEO DOUBLESTAR in Canada?

Yes. TOUJEO DOUBLESTAR 300UNIT has an active shortage reported to Health Canada (last updated November 3, 2026).

When will TOUJEO DOUBLESTAR be available again?

The manufacturer's estimated resolution date is January 15, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file3 products

Expected resolution~2 months remaining (estimate)

Affected strength300UNIT

Report last updated2026-11-03

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

LANTUS

SANOFI-AVENTIS CANADA INC

100UNIT · DIN 02251930

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

BASAGLAR

ELI LILLY CANADA INC

100UNIT · DIN 02444844

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

SEMGLEE

BIOCON SDN.BHD

100UNIT · DIN 02526441

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-01-15

~2 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02493373

Strength

300UNIT

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Active Ingredient

INSULIN GLARGINE

Tier

Unrated

Last Updated

2026-11-03

Reason for Shortage

Other (Please describe in comments)

Source

View original report on healthproductshortages.ca ↗

Other Products from SANOFI-AVENTIS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02464349

10MCG · DIN 02464276

20MCG · DIN 02464284

100UNIT · DIN 02469901

ADMELOG

100UNIT · DIN 02469898

ADMELOG SOLOSTAR

100UNIT · DIN 02469871